See what makesus different

Start the tour

Corona-News

Please find latest news down below.

In the light of the dynamic circumstances around the Coronavirus, LKF would like to reassure you that we are constantly monitoring the situation with the goal of maintaining uninterrupted shipments of our supplies to your clinical sites as well as biological specimens to LKF, while also protecting the health of our employees.

Please always allow some time for a delivery as additional transit time may apply for shipments. Currently we are performing all supplies to the U.S. with FedEx. A Temporary Surcharge on all FedEx and TNT shipments due to restrictions in the global supply chain and limited cargo capacity does apply. The transport of manufacturing goods with Special Express via the country is possible with time delays due to the traffic. Additional costs for transports for all couriers may apply. The possibilities for each transport need to be checked individually. Please get in contact with LKF if you need any support. In case of any questions please contact the project team via email (project(at)lkf-kiel.de) or phone (+49 4307 8276-0).

Please view our Business Continuity Plan for an outbreak of infectious diseases.

Additionally please see  here our press release from the BVMA regarding the system relevanz of CROs not only during COVID-19.

LKF focuses on SARS-CoV-2-analysis: please read here

 

For previously stated information regarding the Coronavirus (COVID-19) outbreak please follow here

Relevant links:

Introducing ourselves

dummy

LKF - Laboratorium für Klinische Forschung GmbH – was established in 1991. The founder, Prof. Dr. W. Junge, M.D., after experience of clinical trials in his medical routine laboratory, recognized the necessity and advantage of forming a separate and specialized medical laboratory unit dedicated exclusively to supporting clinical trials of phases I – IV.


Go directly to our Services 

 

GBAGroup Pharma

News